Incyte faces UK case from Sun Pharma over proposed alopecia drug
By Douglas Clarke-Williams ( September 24, 2025, 12:23 GMT | Insight) -- India's Sun Pharmaceutical Industries is bringing a case against US company Incyte in the UK to have a patent declared invalid and clear the way for it to roll out an alopecia medication based on the drug at the end of next year.India's Sun Pharmaceutical Industries is bringing a case against US company Incyte in the UK to have a patent declared invalid and help clear the way for it to roll out an alopecia medication based on the drug at the end of next year....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.